Resultados da busca - Gustav Gaudernack

Refinar Resultados
  1. 1
    In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen.

    In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. por Gilla Kaplan, Gustav Gaudernack

    Publicado em 1982
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells

    Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells por Jon Amund Kyte, Gustav Gaudernack

    Publicado em 2006
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.

    Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal a... por Stein Sæbøe‐Larssen, Ellen Fossberg, Gustav Gaudernack

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location

    K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location por Jarle Breivik, GI Meling, Anne Spurkland, TO Rognum, Gustav Gaudernack

    Publicado em 1994
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules.

    Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. por Kamal D. Puri, Erik B. Finger, Gustav Gaudernack, T. Springer

    Publicado em 1995
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

    Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine pe... por Marianne Klemp, Jens Bjørheim, Ingvil Sæterdal, June H. Myklebust, Gustav Gaudernack

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination

    Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination por Gaute L. Hansen, Gustav Gaudernack, Paal Brunsvig, Milada Cvancarova, Jon Amund Kyte

    Publicado em 2015
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients

    Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients por Jon Amund Kyte, Gustav Gaudernack, Svein Dueland, Sissel Trachsel, Lars Julsrud, Steinar Aamdal

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001

    Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001 por Else-Marit Inderberg-Suso, Sissel Trachsel, Kari Lislerud, Anne‐Marie Rasmussen, Gustav Gaudernack

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    DEPLETION OF T LYMPHOCYTES FROM HUMAN BONE MARROW

    DEPLETION OF T LYMPHOCYTES FROM HUMAN BONE MARROW por Frode Vartdal, Gunnar Kvalheim, Tor Lea, Vidar Bosnes, Gustav Gaudernack, J. Ugelstad, D Albrechtsen

    Publicado em 1987
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras

    Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras por Synne Wedén, Marianne Klemp, Ivar P. Gladhaug, Mona Møller, Jon Amund Eriksen, Gustav Gaudernack, Trond Buanes

    Publicado em 2010
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces<i>in vivo</i>tumor growth

    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces<i>in vivo</i>tumor growth por Else Marit Inderberg, Sébastien Wälchli, Marit Renée Myhre, Sissel Trachsel, Hilde Almåsbak, Gunnar Kvalheim, Gustav Gaudernack

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes

    hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes por Else-Marit Inderberg-Suso, Svein Dueland, Anne-Marie Rasmussen, Turid Vetrhus, Steinar Aamdal, Gunnar Kvalheim, Gustav Gaudernack

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors

    Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors por Jarle Breivik, Ragnhild A. Lothe, Gunn Iren Meling, Torleiv O. Rognum, Anne‐Lise Børresen‐Dale, Gustav Gaudernack

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

    Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation por Marianne Klemp, Jarle Breivik, Ingvil Sæterdal, Erik Thorsby, Gustav Gaudernack, A. Bakka, O. Søreide, Bjarte G. Solheim

    Publicado em 1995
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study

    Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study por Stephan Bernhardt, Marianne Klemp, Dagmar S. Trachsel, Mona Møller, Jon Amund Eriksen, Maria Lettisia Meo, Trond Buanes, Gustav Gaudernack

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

    Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients por Lijun Mu, Jon Amund Kyte, Gunnar Kvalheim, S. Aamdal, Svein Dueland, M. Häuser, Hege Hammerstad, Håkon Wæhre, Nils Raabe, Gustav Gaudernack

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

    Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial por Paal Brunsvig, Jon Amund Kyte, Christian Kersten, Stein Sundstrøm, Mona Møller, Marta Nyakas, Gaute L. Hansen, Gustav Gaudernack, Steinar Aamdal

    Publicado em 2011
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    A TCR-based Chimeric Antigen Receptor

    A TCR-based Chimeric Antigen Receptor por Even Walseng, Hakan Köksal, Ibrahim M. Sektioglu, Anne Fåne, Gjertrud Skorstad, Gunnar Kvalheim, Gustav Gaudernack, Else Marit Inderberg, Sébastien Wälchli

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells

    Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells por Jon Amund Kyte, Steinar Aamdal, Svein Dueland, Stein Sæbøe-Larsen, Else Marit Inderberg, Ulf Madsbu, Eva Skovlund, Gustav Gaudernack, Gunnar Kvalheim

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: